» Articles » PMID: 8667185

The Effects of Eticlopride and Naltrexone on Responding Maintained by Food, Cocaine, Heroin and Cocaine/heroin Combinations in Rats

Overview
Specialty Pharmacology
Date 1996 Jun 1
PMID 8667185
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

In the first experiment, responding was maintained for food under a fixed ratio (FR) 10 with a 6-min timeout reinforcement schedule. Eticlopride (0.1-1.0 mg/kg i.p.) dose-dependently decreased the number of food pellets obtained, whereas naltrexone (3-30 mg/kg i.p.) did not significantly alter responding. In the second experiment, intravenous self-administration of cocaine (vehicle, 125, 250 and 500 micrograms/infusion), heroin (vehicle, 5.4, 9 and 18 micrograms/infusion) and cocaine/heroin combinations were maintained under a FR10 reinforcement schedule. Cocaine/heroin combinations included the aforementioned cocaine doses combined with 5.4 micrograms/infusion heroin (CH5.4) or 18 micrograms/infusion heroin (CH18). Cocaine/heroin combinations dose-dependently decreased the number of infusions compared with cocaine alone. Eticlopride (0.03-0.3 mg/kg i.p.) decreased self-administration of 125 micrograms/infusion cocaine and increased self-administration of 500 micrograms/infusion cocaine. Self-administration of 250 micrograms/infusion cocaine was increased after 0.03 and 0.1 mg/kg and decreased after 0.3 mg/kg eticlopride. Eticlopride decreased heroin self-administration, an effect which may be attributable to its rate-decreasing effects. Eticlopride partially reversed the downward shift of the CH5.4 group but did not reverse the effect in the CH18 group. Naltrexone (1.0-10.0 mg/kg i.p.) decreased self-administration of 5.4 micrograms/infusion heroin and increased self-administration of 18 micrograms/infusion heroin. Self-administration of 9 micrograms/infusion heroin was increased by 1.0 mg/kg, not affected by 3.0 mg/kg and decreased by 10.0 mg/kg naltrexone. For the CH5.4 and CH18 groups, naltrexone dose-dependently shifted the dose-effect curves toward the cocaine dose-effect curve. Therefore, self-administration of cocaine/heroine combinations can be maintained in the rat and downward shifts in the cocaine dose-effect curve after combination with heroin are mediated through a naltrexone-sensitive mechanism.

Citing Articles

Dopamine D-Like Receptor-Mediated Insurmountable Blockade of the Reinforcing Effects of Cocaine in Rats.

Hiranita T, Soto P, Katz J J Pharmacol Exp Ther. 2024; 391(3):415-429.

PMID: 39443142 PMC: 11585313. DOI: 10.1124/jpet.124.002362.


Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models.

Havel V, Kruegel A, Bechand B, McIntosh S, Stallings L, Hodges A Nat Commun. 2024; 15(1):8118.

PMID: 39304653 PMC: 11415492. DOI: 10.1038/s41467-024-51856-y.


Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder.

Boateng C, Nilson A, Placide R, Pham M, Jakobs F, Boldizsar N J Med Chem. 2023; 66(17):12141-12162.

PMID: 37646374 PMC: 10510399. DOI: 10.1021/acs.jmedchem.3c00734.


Bidirectional influence of heroin and cocaine escalation in persons with dual opioid and cocaine dependence diagnoses.

Butelman E, Chen C, Lake K, Brown K, Kreek M Exp Clin Psychopharmacol. 2020; 30(1):31-38.

PMID: 33119382 PMC: 8388238. DOI: 10.1037/pha0000401.


Changes in fentanyl demand following naltrexone, morphine, and buprenorphine in male rats.

Hammerslag L, Hofford R, Kang Q, Kryscio R, Beckmann J, Bardo M Drug Alcohol Depend. 2019; 207:107804.

PMID: 31862556 PMC: 6981050. DOI: 10.1016/j.drugalcdep.2019.107804.